RSWM
ABBV icon

Robertson Stephens Wealth Management’s AbbVie ABBV Stock Holding History

Robertson Stephens Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
63,757
-92
-0.1% -$19.8K 0.4% 49
2026
Q1 		$13.9M Buy
63,849
+631
+1% +$140K 0.39% 47
2025
Q4 		$14.4M Buy
63,218
+34,246
+118% +$7.8M 0.38% 46
2025
Q3 		$6.71M Sell
28,972
-448
-2% -$91.2K 0.2% 85
2025
Q2 		$5.46M Sell
29,420
-421
-1% -$78.2K 0.17% 96
2025
Q1 		$6.25M Sell
29,841
-3,222
-10% -$626K 0.22% 88
2024
Q4 		$5.88M Buy
33,063
+1,045
+3% +$192K 0.21% 97
2024
Q3 		$6.32M Buy
32,018
+6,323
+25% +$1.18M 0.23% 93
2024
Q2 		$4.41M Buy
25,695
+1,185
+5% +$196K 0.22% 85
2024
Q1 		$4.46M Buy
24,510
+3,133
+15% +$540K 0.24% 74
2023
Q4 		$3.31M Sell
21,377
-288
-1% -$42K 0.2% 91
2023
Q3 		$3.23M Buy
21,665
+250
+1% +$36.7K 0.22% 98
2023
Q2 		$2.89M Buy
21,415
+4,717
+28% +$692K 0.2% 108
2023
Q1 		$2.66M Buy
16,698
+1,233
+8% +$189K 0.2% 103
2022
Q4 		$2.5M Sell
15,465
-122
-0.8% -$18.7K 0.24% 92
2022
Q3 		$2.09M Sell
15,587
-2,108
-12% -$302K 0.22% 90
2022
Q2 		$2.71M Buy
17,695
+1,019
+6% +$156K 0.26% 86
2022
Q1 		$2.7M Sell
16,676
-1,933
-10% -$281K 0.23% 87
2021
Q4 		$2.52M Buy
18,609
+9,685
+109% +$1.14M 0.21% 95
2021
Q3 		$962K Sell
8,924
-1,755
-16% -$201K 0.11% 124
2021
Q2 		$1.2M Buy
10,679
+315
+3% +$35.5K 0.14% 105
2021
Q1 		$1.12M Buy
10,364
+785
+8% +$84K 0.18% 95
2020
Q4 		$1.03M Buy
9,579
+1,554
+19% +$149K 0.21% 87
2020
Q3 		$702K Sell
8,025
-1,568
-16% -$148K 0.17% 110
2020
Q2 		$941K Sell
9,593
-3,100
-24% -$273K 0.27% 74
2020
Q1 		$967K Buy
12,693
+5,609
+79% +$478K 0.33% 67
2019
Q4 		$627K Sell
7,084
-6,479
-48% -$538K 0.32% 52
2019
Q3 		$1.03M Buy
+13,563
New +$930K 0.52% 42

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Robertson Stephens Wealth Management's ABBV Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its AbbVie (ABBV) stake by 0.14% in Q2 2026, selling an estimated $19.8K and leaving 63,757 shares worth $16M. The position accounts for 0.4% of the portfolio, ranked #49.

Robertson Stephens Wealth Management first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 2,057 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Robertson Stephens Wealth Management held 63,757 shares of AbbVie worth $16M as of Q2 2026.
  • Robertson Stephens Wealth Management sold 92 AbbVie shares in Q2 2026, an estimated $19.8K.
  • AbbVie made up 0.4% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Robertson Stephens Wealth Management first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 2,057 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.